For the good of the patient: risks and benefits of medicines

被引：8
|
作者：
Breckenridge, A [1 ]
机构：
[1] Univ Liverpool, Dept Pharm & Therapeut, Liverpool L69 3BX, Merseyside, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2003年 / 12卷 / 02期
关键词：
medicines; risks; benefits; pharmacovigilance;
D O I：
10.1002/pds.805
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The basis of regulation of medicines is an assessment of risk and benefit. As the process of drug development has evolved with the advances in scientific knowledge, new and more precise methods of measuring drug efficacy have been created. Pharmacovigilance must also change with as much emphasis being placed on demonstrating the safety of a medicine as on preventing harm. Communication of these issues to interested parties remains problematical with room for considerable improvement. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码：145 / 150
页数：6
相关论文
共 50 条
12345